4.7 Review

New insights into form and function of fibronectin splice variants

期刊

JOURNAL OF PATHOLOGY
卷 216, 期 1, 页码 1-14

出版社

WILEY
DOI: 10.1002/path.2388

关键词

pulmonary fibrosis; arterial thrombosis; alternative splicing; fibronectin isoforms; atherosclerosis; mouse models; transgenic mice

资金

  1. National Institutes of Health [HL083085]
  2. T. Franklin Williams Geriatrics Research Development Award
  3. CHEST Foundation
  4. Martin E. Galvin Fund and Quest for Breath Foundation
  5. NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL083085, R01HL085083] Funding Source: NIH RePORTER

向作者/读者索取更多资源

The extracellular matrix (ECM) is a highly dynamic structure that not only provides a physical framework for cells within connective tissues, but also imparts instructive signals for development, tissue homeostasis and basic cell functions through its composition and ability to exert mechanical forces. The ECM of tissues is composed of, in addition to proteoglycans and hyaluronic acid, a number of proteins, most of which are generated after alternative splicing of their pre-mRNA. However, the precise function of these protein isoforms is still obscure in most cases. Fibronectin (FN), one of the main components of the ECM, is also one of the best-known examples of a family of proteins generated by alternative splicing, having at least 20 different isoforms in humans. Over the last few years, considerable progress on elucidating the functions of the alternatively spliced FN isoforms has been achieved with the essential development of key engineered mouse strains. Here we summarize the phenotypes of the mouse strains having targeted mutations in the FN gene, which may lead to novel insights linking function of alternatively spliced isoforms of fibronectin to human pathologies. Copyright (C) 2008 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据